ARPO Market Cap History



Below is a table of the ARPO market cap history going back to 5/15/2018:

Date ARPO Market Cap
5/15/2018109.95M
6/26/2018183.87M
8/14/2018149.74M
11/7/201885.23M
3/1/2019120.55M
5/7/201942.62M
8/6/201927.92M
12/31/201837.59M
11/6/201922.53M
3/9/202024.03M
5/6/202025.61M
8/10/202067.31M
11/6/202061.25M
3/8/202170.97M
5/12/202154.95M
8/9/2021101.52M

Also see: ARPO Shares Outstanding History
and ARPO YTD Return
ARPO Historical Market Cap:
-2.43% CAGR
ARPO Historical Market Cap: +-2.43% CAGR

Mouse over chart for data details
5/15/2018 ...8/9/2021
Aerpio Pharmaceuticals is a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications. Co.'s main product candidate, AKB-9778, a small molecule inhibitor of the Tie2 pathway, is being developed for the treatment of non-proliferative diabetic retinopathy. AKB-9778 works by inhibiting vascular endothelial protein tyrosine phosphatase, an enzyme that is upregulated in diabetic eye disease and that is responsible for inactivating Tie2. Co. has AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1 alpha). AKB-4924, now called GB004, is being developed for the treatment of inflammatory bowel disease. We show 16 historical shares outstanding datapoints in our ARPO shares outstanding history coverage, used to compute ARPO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARPO market cap history over the course of time is important for investors interested in comparing ARPO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARPO versus a peer is one thing; comparing ARPO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARPO can fluctuate over the course of history. With this page we aim to empower investors researching ARPO by allowing them to research the ARPO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ARPO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aerpio Pharmaceuticals (ARPO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ARQL Market Cap History
ARQT Market Cap History
ARTL Market Cap History
ARVN Market Cap History
ARWR Market Cap History
ASMB Market Cap History
ASPI Market Cap History
ASRT Market Cap History
ASTH Market Cap History
ATEC Market Cap History
More Healthcare companies »

 

ARPO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.